Thursday, April 20, 2017

#ILC2017 International Liver Congress/Healio - Expert weighs risks and benefits of HCV-positive liver donation

Expert weighs risks and benefits of HCV-positive liver donation
April 20, 2017

AMSTERDAM — While hepatitis C virus-positive liver donation into HCV-positive recipients solves a number of public health problems, donation into HCV-negative recipients remains controversial, according to a presenter at the International Liver Congress.

Samuel said that there is not yet sufficient evidence to assess the safety of positive to negative donation. “We suggest limited use of positive grafts in negative patients, but there are no solid data to support this statement,” he said. “It should be restricted except in cases of high clinical need. Also, graft quality should be cautiously evaluated. Initiation of DAA therapy should as soon as possible, usually within 3 to 6 months.”

Meeting Coverage Healio
International Liver Congress

International Liver Congress™ 2017
Updates On This Blog

No comments:

Post a Comment